HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5,19- cyclo- 9beta,10xi- androstane- 3,17- dione

structure in first source

Also Known As:

CAD compound

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Wang, Tianshuang: 1 article (01/2020)
2.	Wu, Ye: 1 article (01/2020)
3.	Xu, Han: 1 article (01/2020)
4.	Zhou, Ling: 1 article (01/2020)
5.	Chiba, Toshiki: 1 article (12/2007)
6.	Haganuma, Asami: 1 article (12/2007)
7.	Kikuchi, Haruhisa: 1 article (12/2007)
8.	Mori, Koichiro: 1 article (12/2007)
9.	Murakami, Shinsuke: 1 article (12/2007)
10.	Nakagawasai, Osamu: 1 article (12/2007)

Related Diseases

1.	Astrocytoma (Pilocytic Astrocytoma) 12/12/2007 - "5,19-cyclo-9beta,10xi-androstane-3,17-dione promotes neurotrophic factor biosynthesis in 1321N1 human astrocytoma cells and improves passive avoidance learning impairment."
2.	Anemia 01/01/2020 - "Trio whole-exome sequencing identified CAD compound heterozygous mutations in a new male patient with global developmental delay (DD), refractory epilepsy, and anemia with anisopoikilocytosis. "
3.	Drug Resistant Epilepsy 01/01/2020 - "Trio whole-exome sequencing identified CAD compound heterozygous mutations in a new male patient with global developmental delay (DD), refractory epilepsy, and anemia with anisopoikilocytosis. "

Related Drugs and Biologics

1.	Nerve Growth Factors (Neurotrophins)